MARKET

IMUC

IMUC

EOM Pharmaceutical Holdings Inc
OTCPK
0.067
NaN%
Closed 09:30 07/11 EDT
OPEN
--
PREV CLOSE
0.067
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.200
52 WEEK LOW
0.067
MARKET CAP
8.49M
P/E (TTM)
-1.7941
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at IMUC last week (0630-0704)?
Weekly Report · 5d ago
Weekly Report: what happened at IMUC last week (0623-0627)?
Weekly Report · 06/30 11:05
Weekly Report: what happened at IMUC last week (0616-0620)?
Weekly Report · 06/23 10:58
Weekly Report: what happened at IMUC last week (0609-0613)?
Weekly Report · 06/16 11:05
Weekly Report: what happened at IMUC last week (0602-0606)?
Weekly Report · 06/09 11:06
Weekly Report: what happened at IMUC last week (0526-0530)?
Weekly Report · 06/02 11:14
Weekly Report: what happened at IMUC last week (0519-0523)?
Weekly Report · 05/26 11:13
Weekly Report: what happened at IMUC last week (0512-0516)?
Weekly Report · 05/19 11:04
More
About IMUC
EOM Pharmaceutical Holdings, Inc., through its wholly owned subsidiary EOM Pharmaceuticals, Inc., is a clinical-stage biotechnology company. The Company is focused on developing drugs with the potential to transform therapeutic paradigms and improve quality of life in patients suffering from debilitating and sometimes deadly diseases. Its pipeline includes its lead compound EOM613, an investigational novel dynamically dual-acting immunomodulator. EOM613 is a peptide nucleic-acid solution with both anti-inflammatory and pro-inflammatory broad spectrum cytokine effects. Human cell culture studies demonstrate that EOM613 can suppress or stimulate monocytes and macrophages depending on the activation state and environment of those key immune cells, resulting in either further activation or suppression. Its pipeline also includes EOM147, an investigational, broad-spectrum aminosterol with an intracellular mechanism for the treatment of retinal diseases.

Webull offers Eom Pharmaceutical Holdings Inc stock information, including OTCPK: IMUC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IMUC stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IMUC stock methods without spending real money on the virtual paper trading platform.